Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EMA Guide On Trial Master Files To Help Compliance With Upcoming CT Regulation

Executive Summary

The European Medicines Agency has issued a new draft guideline to clarify its regulatory expectations relating to the maintenance of clinical trial master files in line with the upcoming EU Clinical Trials Regulation.

You may also be interested in...

EU Inspectors Find More Than 1,000 Clinical Trial Deficiencies

The number of deficiencies found by EU GCP inspectors rose to 1,033 in 2016, compared with 912 in 2015, although the number of problematic findings considered “critical” was down slightly. Meanwhile, Japan has asked to join the EMA/FDA initiative on GCP inspections.

EMA explains how firms can avoid common problems in drug trial master files

The European Medicines Agency is inviting feedback on a draft reflection paper that explains how companies can comply with good clinical practice (GCP) requirements in relation to trial master files, whether these are maintained in paper or electronic formats1.

New Zealand Mandates Labeling Changes To Warn About Certain Allergens

Sponsors of new and existing medicines in New Zealand will have to update their product labels within specified deadlines to include warning statements about certain allergens.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts